Ambio Holdings, Inc is a startup based in the United States, most recent round Series-c-plus.
Based in the United States, Ambio Holdings, Inc is a startup. Its most recent tracked round is Series-c-plus.
Ambio Holdings, Inc is a contract development and manufacturing organization (CDMO) that develops and manufactures peptide active pharmaceutical ingredients (APIs) and peptide-based therapeutics, and provides formulation and cGMP manufacturing services with operations in the United States and China.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.